4
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Cell Kinetic Study on Experimental Tongue Carcinoma in Rats

, &
Pages 314-320 | Received 18 Sep 1989, Accepted 08 Mar 1990, Published online: 08 Jul 2009
 

Abstract

Tongue carcinomas were produced in rats by oral administration of 0.001 % 4-nitroquino-line 1-oxide (4NQO) in drinking water, and the biological characteristics and tumor kinetics were correlated. Bromodeoxyuridine (BrdU) was used to investigate cell kinetics of rat tongue tumors in vivo. BrdU-labeled S-phase cells were demonstrated by an indirect peroxidase method using anti-BrdU monoclonal antibody, and their percentage, the labeling index (L.I.), was determined. The average BrdU L.I. in normal tongue epithelium, well differentiated and moutrately differentiated squamous cell carcinoma was 5.7±1.1, 8.8±3.7 and 14.9±5.4, respectively. The differences among the three groups are significant. These results indicate that the BrdU L.I. correlates well with the degree of differentiation of tongue epithelium. Furthermore, the distribution patterns of BrdU-labeled cells in the tissue sections of each group were different. If these cell kinetics studies using BrdU are applied to human tongue carcinomas, the data may provide information on the biological characteristics and help in establishing the diagnosis and in choosing treatment regimens.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.